A series of experiments were conducted to investigate the involvement of CXCL2 in regulating the metastatic potential of HCC cells; our result indicated that recombinant human CXCL2 could significantly increase the migratory ability of HCC cells compared with untreated cells, in any concentration chosen. The gene discussed is CXCL2; the disease is hepatocellular carcinoma.